Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line. [electronic resource]
Producer: 20090421Description: 5403-11 p. digitalISSN:- 2219-2840
- Adenocarcinoma -- drug therapy
- Animals
- Antineoplastic Agents -- therapeutic use
- Apoptosis -- drug effects
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride
- Humans
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Neovascularization, Pathologic -- drug therapy
- Pancreatic Neoplasms -- drug therapy
- Protein Kinase Inhibitors -- therapeutic use
- Quinazolines -- therapeutic use
- Transplantation, Heterologous
- Vascular Endothelial Growth Factor A -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.